1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Gemtuzumab-ozogamicin (GO; Mylotarg®) as part of consolidation therapy for AML before autograft: Low incidence of hepatic veno-occlusive disease

      , , , , ,
      Biology of Blood and Marrow Transplantation
      Elsevier BV

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          Biology of Blood and Marrow Transplantation
          Biology of Blood and Marrow Transplantation
          Elsevier BV
          10838791
          February 2005
          February 2005
          : 11
          : 2
          : 62-63
          Article
          10.1016/j.bbmt.2004.12.187
          152c72ed-ac69-4cfa-a8af-126f0c429b3e
          © 2005

          http://www.elsevier.com/tdm/userlicense/1.0/

          http://creativecommons.org/licenses/by-nc-nd/4.0/

          History

          Comments

          Comment on this article